KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$2.4 million.

  • Biolife Solutions' Net Cash Flow fell 21639.42% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 884.59%. This contributed to the annual value of $59.9 million for FY2024, which is 27632.14% up from last year.
  • Latest data reveals that Biolife Solutions reported Net Cash Flow of -$2.4 million as of Q3 2025, which was down 21639.42% from -$35.0 million recorded in Q2 2025.
  • Biolife Solutions' Net Cash Flow's 5-year high stood at $71.2 million during Q4 2024, with a 5-year trough of -$35.3 million in Q2 2022.
  • Over the past 5 years, Biolife Solutions' median Net Cash Flow value was -$2.4 million (recorded in 2025), while the average stood at -$3.2 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 279791.67% in 2021, then soared by 40794.3% in 2022.
  • Over the past 5 years, Biolife Solutions' Net Cash Flow (Quarter) stood at -$5.4 million in 2021, then tumbled by 41.34% to -$7.7 million in 2022, then surged by 310.25% to $16.1 million in 2023, then soared by 341.96% to $71.2 million in 2024, then plummeted by 103.4% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q3 2025, -$35.0 million for Q2 2025, and -$28.4 million during Q1 2025.